Results 11 to 20 of about 1,693 (197)
Management of preterm labor: atosiban or nifedipine?
International Journal of Women's Health, 2010 Roel de Heus, Eduard J H Mulder, Gerard H A VisserDepartment of Woman and Baby, University Medical Centre Utrecht, The NetherlandsAbstract: Preterm birth is strongly associated with neonatal death and long-term neurological morbidity.
Roel de Heus +2 more
doaj +7 more sources
Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles
Scientific Reports, 2023 Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patients.
Xiufang Li +6 more
doaj +2 more sources
Atosiban in the Management of Preterm Labour [PDF]
Clinical Medicine Insights: Women's Health, 2011 The purpose of this review was to look at the evidence available for the use of atosiban as a tocolytic in cases of threatened preterm labour. A Royal College of Obstetricians and Gynaecologists Green Top Guideline concluded that there was no clear evidence to show a benefit to tocolysis in reducing perinatal and neonatal morbidity and mortality ...
Fullerton, Gail M +3 more
openaire +4 more sources
BMC Pregnancy and Childbirth, 2022 Background Worldwide, nifedipine and atosiban are the two most commonly used tocolytic agents for the treatment of threatened preterm birth. The aim of this study was to evaluate the effectiveness of nifedipine and atosiban in an individual participant ...
Tijn M. S. van Winden +9 more
doaj +2 more sources
A Comparative Study to Determine the Efficacy of Atosiban versus Nifedipine in Management of Preterm Labour [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Preterm Labour (PTL) remains a significant challenge in obstetrics, contributing to neonatal morbidity and mortality. The management of PTL involves the use of tocolytic agents to delay delivery, thereby allowing for further foetal ...
Vidya Gaikwad, Jay Patel, Suhas Gaikwad
doaj +2 more sources
, 2007 Atosiban is a synthetic analog of oxytocin and acts as a competitive antagonist at the oxytocin receptor. Atosiban is used in the management of preterm labor (labor occurring before 37 weeks of gestation).
Kay Marshall, Marshall, K.; id_orcid
openaire +2 more sources
Atosiban interacts with growth hormones as adjuvants in frozen-thawed embryo transfer cycles [PDF]
Frontiers in EndocrinologyObjectiveTo investigate the interaction between atosiban and growth hormone (GH) as adjuvants in frozen-thawed embryo transfer (FET) cyclesMethodA total of 11627 patients who underwent FET at Xiamen University Affiliated Chenggong Hospital between ...
Haixiao Chen +12 more
doaj +2 more sources
Taiwanese Journal of Obstetrics & Gynecology, 2010 Objective: Pregnancies with extremely preterm premature rupture of membranes (EPPROM), especially before 20 weeks of gestation, are usually considered to be a termination of pregnancy.
Ming-Yih Wu +4 more
doaj +2 more sources
Randomized Trial of Oxytocin Antagonist Atosiban Versus Beta-adrenergic Agonists in the Treatment of Spontaneous Preterm Labor in Taiwanese Women [PDF]
Journal of the Formosan Medical Association, 2009 Management of preterm labor involves the use of tocolytic drugs to inhibit preterm uterine contractions. This study compared the efficacy and safety of intravenous administration of atosiban and ritodrine in the treatment of spontaneous preterm labor ...
Chia-Hui Lin +4 more
doaj +3 more sources
COMPAREMENT OF LOCALIZA ATOSIBAN AND HEXOPRENALINE IN PREMATURE DELIVERY BEFORE 32 AND AFTER 32 WEEKS OF PREGNANCY [PDF]
Медицинский совет, 2017 The aim of the study was to compare the efficacy of tocolytic agents - hexoprenaline and atosiban taking into account the gestational age.Patients and methods.
O. R. Baev +3 more
doaj +2 more sources